Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
1989513 citationsPiero De Stefano, Caterina Borgna‐Pignatti et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of S Terzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Terzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Terzoli more than expected).
This network shows the impact of papers produced by S Terzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Terzoli. The network helps show where S Terzoli may publish in the future.
Co-authorship network of co-authors of S Terzoli
This figure shows the co-authorship network connecting the top 25 collaborators of S Terzoli.
A scholar is included among the top collaborators of S Terzoli based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Terzoli. S Terzoli is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Fesslová, Vlasta, et al.. (1995). Rhythm and conduction anomalies in young children and adolescents with thalassemia major - Part 2: Long-term influence of the new therapeutic management. 21(5). 670–674.1 indexed citations
Carnelli, V., et al.. (1992). [New therapeutic trends in thalassemia: oral chelating agents].. PubMed. 14(3). 273–5.3 indexed citations
4.
Sansone, G, Giuseppe Masera, S Terzoli, & A Cantù-Rajnoldi. (1990). Congenital refractory anaemia with vacuolisation of bone marrow precursors, sideroblastosis and growth failure in a girl with normal endocrine pancreatic function.. PubMed. 74(6). 587–90.6 indexed citations
5.
Stefano, Piero De, Caterina Borgna‐Pignatti, C Melevendi, et al.. (1989). SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR. The Lancet. 334(8653). 27–30.513 indexed citations breakdown →
6.
Moretti, Elena, et al.. (1989). [Audiologic evaluation of patients with thalassemic syndromes treated with desferrioxamine B].. PubMed. 10(5). 503–4.2 indexed citations
7.
Borgna‐Pignatti, Caterina, et al.. (1989). Survival in thalassemia with conventional treatment.. PubMed. 309. 27–33.9 indexed citations
Bíanchi, C, et al.. (1982). [Biochemical data in the phosphate depletion syndrome of thalassemic patient (author's transl)].. PubMed. 3(1). 15–21.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.